propiconazole has been researched along with idarubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, R; Horibe, K; Kobayashi, R; Tawa, A; Tsuchida, M; Tsukimoto, I | 1 |
| Brierley, CK; Eyre, TA | 1 |
| Cheng, Y; Guo, L; Ma, X; Yu, C; Zhang, Y; Zhu, S | 1 |
3 other study(ies) available for propiconazole and idarubicin
| Article | Year |
|---|---|
Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Central Nervous System; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gingiva; Humans; Hydrocortisone; Idarubicin; Infant; Infant, Newborn; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Leukemic Infiltration; Male; Methotrexate; Orbit; Prognosis; Remission Induction; Sarcoma, Myeloid; Skin; Testis | 2007 |
Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Ear, External; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hearing Loss, Unilateral; Humans; Idarubicin; Leukemia, Monocytic, Acute; Leukemic Infiltration; Male; Orbit; Tumor Lysis Syndrome; Vidarabine | 2017 |
Nonleukemic granulocytic sarcoma of orbit after blunt trauma: A case report and review of literature.
Topics: Adult; Antineoplastic Agents; Causality; Cytarabine; Early Detection of Cancer; Eye Injuries; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Magnetic Resonance Imaging; Ophthalmologic Surgical Procedures; Orbit; Orbital Neoplasms; Radiotherapy; Sarcoma, Myeloid; Tomography, X-Ray Computed; Treatment Outcome; Wounds, Nonpenetrating | 2018 |